Breaking: Erythromelalgia Treatment Market Size Set to Soar by 2035
The Erythromelalgia Treatment Market Size is positioned for substantial growth, projected to escalate to USD 179.31 million by 2035. This growth trajectory reflects a compound annual growth rate (CAGR) of 5.50% from its 2022 valuation of USD 2.5 million. The increasing prevalence of erythromelalgia, coupled with heightened awareness and patient advocacy, is significantly driving this...
0 Comments 0 Shares 82 Views 0 Reviews